Beijing Wantai Financials
| 603392 Stock | 66.04 0.29 0.44% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Income | 1.5 B | 1.9 B |
|
|
Beijing | Select Account or Indicator |
Understanding current and past Beijing Wantai Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Beijing Wantai's financial statements are interrelated, with each one affecting the others. For example, an increase in Beijing Wantai's assets may result in an increase in income on the income statement.
Please note, the presentation of Beijing Wantai's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Beijing Wantai's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Beijing Wantai's management manipulating its earnings.
Beijing Wantai Stock Summary
Beijing Wantai competes with Beijing Watertek, BlueFocus Communication, Wonders Information, Sichuan Jinshi, and Fujian Newland. Beijing Wantai is entity of China. It is traded as Stock on SHG exchange.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | China Stock View All |
| Exchange | Shanghai Stock Exchange |
| ISIN | CNE100004090 |
| Business Address | No 31 Science |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.ystwt.com |
| Phone | 86 10 5952 8888 |
You should never invest in Beijing Wantai without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Beijing Stock, because this is throwing your money away. Analyzing the key information contained in Beijing Wantai's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Beijing Wantai Key Financial Ratios
Beijing Wantai's financial ratios allow both analysts and investors to convert raw data from Beijing Wantai's financial statements into concise, actionable information that can be used to evaluate the performance of Beijing Wantai over time and compare it to other companies across industries.| Revenue | 5.51 B | ||||
| Gross Profit | 1.53 B | ||||
| EBITDA | (122.77 M) | ||||
| Net Income | 1.25 B | ||||
| Total Asset | 15.71 B |
Beijing Wantai Key Balance Sheet Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Total Assets | 3.5B | 7.0B | 16.2B | 15.7B | 18.1B | 19.0B | |
| Other Current Liab | 203.3M | 421.5M | 480.6M | 3.8M | 3.4M | 3.2M | |
| Other Liab | 71.2M | 94.3M | 80.2M | 58.5M | 52.7M | 59.9M | |
| Net Tangible Assets | 1.3B | 2.3B | 4.2B | 12.0B | 13.8B | 14.5B | |
| Retained Earnings | 1.7B | 3.4B | 7.9B | 7.6B | 8.7B | 9.1B | |
| Accounts Payable | 107.3M | 154.1M | 275.5M | 389.6M | 448.0M | 470.4M | |
| Cash | 710.7M | 1.4B | 5.2B | 3.8B | 4.4B | 4.6B | |
| Other Assets | 190.4M | 297.0M | 337.6M | 602.9M | 693.4M | 728.1M | |
| Net Receivables | 691.3M | 2.3B | 3.9B | 3.0B | 3.4B | 3.6B | |
| Inventory | 400.0M | 593.2M | 869.1M | 905.5M | 1.0B | 1.1B | |
| Other Current Assets | 39.5M | 105.2M | 139.4M | 495.1M | 569.4M | 597.9M | |
| Total Liab | 923.3M | 2.5B | 3.7B | 2.8B | 3.3B | 1.7B | |
| Total Current Assets | 2.0B | 4.6B | 12.2B | 10.3B | 11.8B | 12.4B | |
| Intangible Assets | 233.9M | 295.1M | 332.4M | 642.7M | 739.2M | 776.1M | |
| Net Invested Capital | 2.6B | 4.7B | 12.6B | 12.9B | 14.8B | 15.6B | |
| Net Working Capital | 1.1B | 2.3B | 8.7B | 7.6B | 8.8B | 9.2B | |
| Capital Stock | 433.6M | 607.0M | 906.1M | 1.3B | 1.5B | 732.4M |
Beijing Wantai Key Income Statement Accounts
An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Tax Provision | 82.6M | 244.9M | 719.4M | 146.9M | 168.9M | 171.5M | |
| Net Interest Income | (11.4M) | 3.6M | 33.7M | 80.0M | 92.0M | 96.6M | |
| Interest Income | 1.2B | 9.8M | 42.2M | 88.0M | 101.2M | 187.2M | |
| Interest Expense | 1.7M | 5.7M | 7.7M | 6.9M | 7.9M | 4.0M | |
| Total Revenue | 2.4B | 5.8B | 11.2B | 5.5B | 6.3B | 4.0B | |
| Gross Profit | 1.9B | 4.9B | 10.0B | 4.7B | 5.4B | 3.4B | |
| Operating Income | 825.7M | 2.4B | 5.6B | 1.6B | 1.9B | 1.5B | |
| Ebit | 149.3M | 724.7M | 2.2B | 5.3B | 6.1B | 6.4B | |
| Research Development | 314.3M | 681.8M | 1.1B | 1.2B | 1.4B | 1.4B | |
| Cost Of Revenue | 442.1M | 817.7M | 1.2B | 792.1M | 910.9M | 595.9M | |
| Income Before Tax | 764.5M | 2.3B | 5.6B | 1.4B | 1.6B | 1.5B | |
| Net Income | 677.0M | 2.0B | 4.7B | 1.2B | 1.4B | 1.3B | |
| Income Tax Expense | 6.5M | 82.6M | 244.9M | 719.4M | 827.3M | 868.7M | |
| Minority Interest | 26.7M | (57.7M) | (127.5M) | 1.2M | 1.1M | 1.1M | |
| Ebitda | 298.4M | 850.6M | 2.4B | 5.7B | 6.6B | 6.9B |
Beijing Wantai Key Cash Accounts
Cash flow analysis captures how much money flows into and out of Beijing Wantai Biological. It measures of how well Beijing is doing because it can show the actual money that comes into and out of the Company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money Beijing Wantai brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money Beijing had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what Beijing Wantai has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Investments | 86.5M | 14.4M | (2.6B) | (2.1B) | (1.8B) | (1.8B) | |
| Change In Cash | 543.6M | 711.9M | 3.8B | (1.4B) | (1.6B) | (1.5B) | |
| Capital Expenditures | 390.4M | 1.0B | 929.9M | 1.2B | 1.3B | 1.4B | |
| Net Income | 677.0M | 2.0B | 4.7B | 1.2B | 1.4B | 1.3B | |
| End Period Cash Flow | 701.5M | 1.4B | 5.2B | 3.8B | 4.4B | 4.6B | |
| Change To Netincome | 5.3M | 56.9M | 170.5M | 176.9M | 203.4M | 213.6M | |
| Change To Inventory | (190.7M) | (223.0M) | (296.5M) | (218.3M) | (196.5M) | (206.3M) | |
| Free Cash Flow | 77.8M | 634.2M | 3.2B | 378.2M | 434.9M | 675.4M | |
| Depreciation | 84.5M | 105.3M | 148.7M | 231.5M | 266.2M | 279.6M | |
| Other Non Cash Items | 14.9M | 14.8M | (12.0M) | 23.3M | 26.8M | 28.2M | |
| Dividends Paid | 1.7M | 112.7M | 128.1M | 907.5M | 1.0B | 1.1B |
Beijing Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Beijing Wantai's current stock value. Our valuation model uses many indicators to compare Beijing Wantai value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Beijing Wantai competition to find correlations between indicators driving Beijing Wantai's intrinsic value. More Info.Beijing Wantai Biological is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Beijing Wantai by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Beijing Wantai's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Beijing Wantai Biological Systematic Risk
Beijing Wantai's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Beijing Wantai volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Beijing Wantai Biological correlated with the market. If Beta is less than 0 Beijing Wantai generally moves in the opposite direction as compared to the market. If Beijing Wantai Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Beijing Wantai Biological is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Beijing Wantai is generally in the same direction as the market. If Beta > 1 Beijing Wantai moves generally in the same direction as, but more than the movement of the benchmark.
Beijing Wantai Biological Total Assets Over Time
Beijing Wantai March 27, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Beijing Wantai help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Beijing Wantai Biological. We use our internally-developed statistical techniques to arrive at the intrinsic value of Beijing Wantai Biological based on widely used predictive technical indicators. In general, we focus on analyzing Beijing Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Beijing Wantai's daily price indicators and compare them against related drivers.
| Information Ratio | (0.1) | |||
| Maximum Drawdown | 11.84 | |||
| Value At Risk | (2.83) | |||
| Potential Upside | 2.84 |
Complementary Tools for Beijing Stock analysis
When running Beijing Wantai's price analysis, check to measure Beijing Wantai's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Beijing Wantai is operating at the current time. Most of Beijing Wantai's value examination focuses on studying past and present price action to predict the probability of Beijing Wantai's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Beijing Wantai's price. Additionally, you may evaluate how the addition of Beijing Wantai to your portfolios can decrease your overall portfolio volatility.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |